Literature DB >> 1559055

Screening for cervical cancer by direct inspection.

V Singh1, A Sehgal, U K Luthra.   

Abstract

OBJECTIVE: To assess the efficacy of visual screening for cervical cancer in the maternal and child health setting.
DESIGN: Clinical and cytological screening.
SETTING: Maternal and child health centres, Delhi.
SUBJECTS: 44,970 women attending the centres from May 1988 to March 1991.
RESULTS: 238 cancers in early stages (0-IIa) were detected cytologically and proved through biopsy. Prevalence of cancer in women defined as high risk through examination by speculum was 29/1000 as compared to 1.53/1000 among women with a normal looking cervix. Though only 11.4% women belonged to the high risk category, 63% had early stage cancer. If all women with bleeding symptoms were included in the high risk category, the yield of cancer would be 71.4% (170/238) by referring only 15.6% of women attending maternal and child health centres for further evaluation through cytology or colposcopy.
CONCLUSION: Though visual screening is a suboptimal strategy in comparison to the cytological screening, it may be useful where there is a heavy load of prevalent cancer and where cytological screening may not be available for years to come.

Entities:  

Mesh:

Year:  1992        PMID: 1559055      PMCID: PMC1881403          DOI: 10.1136/bmj.304.6826.534

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  1 in total

1.  Screening for cervical cancer by direct inspection.

Authors:  A Sehgal; V Singh; S Bhambhani; U K Luthra
Journal:  Lancet       Date:  1991-08-03       Impact factor: 79.321

  1 in total
  11 in total

1.  Asian society of gynecologic oncology workshop 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Mohamad Farid Aziz; Uma K Devi; Hextan Y S Ngan; Joo-Hyun Nam; Seung Cheol Kim; Tomoyasu Kato; Hee Sug Ryu; Shingo Fujii; Yoon Soon Lee; Jong Hyeok Kim; Tae-Joong Kim; Young Tae Kim; Kung-Liahng Wang; Taek Sang Lee; Kimio Ushijima; Sang-Goo Shin; Yin Nin Chia; Sarikapan Wilailak; Sang Yoon Park; Hidetaka Katabuchi; Toshiharu Kamura; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Screening for cervical cancer in developing countries.

Authors:  M Griffiths
Journal:  BMJ       Date:  1992-04-11

3.  Screening for cervical cancer in developing countries.

Authors:  M M Soe
Journal:  BMJ       Date:  1992-04-11

4.  Fluorescence spectroscopy: a new approach in cervical cancer.

Authors:  Kiran Pandey; Asima Pradhan; Asha Agarwal; Ajay Bhagoliwal; Nidhi Agarwal
Journal:  J Obstet Gynaecol India       Date:  2012-10-23

5.  Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India.

Authors:  Surendra S Shastri; Indraneel Mittra; Gauravi A Mishra; Subhadra Gupta; Rajesh Dikshit; Shalini Singh; Rajendra A Badwe
Journal:  J Natl Cancer Inst       Date:  2014-02-22       Impact factor: 13.506

6.  Optical Imaging: Future Tool in Detection of Pre-cancerous and Cancerous Lesions of Cervix and Its Comparison to Colposcopy.

Authors:  Kiran Pandey; Ajay Bhagoliwal; Sonal Jain
Journal:  J Obstet Gynaecol India       Date:  2014-07-15

7.  Cervical cancer screening in Tamilnadu, India: a feasibility study of training the village health nurse.

Authors:  C K Gajalakshmi; S Krishnamurthi; R Ananth; V Shanta
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

Review 8.  Cervical cancer prevention--cervical screening: science in evolution.

Authors:  Mahboobeh Safaeian; Diane Solomon; Philip E Castle
Journal:  Obstet Gynecol Clin North Am       Date:  2007-12       Impact factor: 2.844

9.  Evaluation of visual inspection as a screening test for cervical cancer.

Authors:  R Wesley; R Sankaranarayanan; B Mathew; B Chandralekha; A Aysha Beegum; N S Amma; M K Nair
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix.

Authors:  P Ghosh; G Gandhi; P K Kochhar; V Zutshi; S Batra
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.